SCCM
Log In
Forgot username or password?
New User? Sign Up Free.

Industry Education

The Society of Critical Care Medicine’s (SCCM) 49th Critical Care Congress will be packed with essential clinical information to keep you informed on the latest groundbreaking research and developments in critical care. Each year, industry partners invest significant resources in research and development, placing them at the cutting edge of clinical practice.​​​​​

View the 49th Critical Care Congress Special Events and Sessions Brochure.
 
Industry partners invest significant resources in research and development, and stand at the cutting edge of clinical practice. These programs, developed and sponsored by industry partners, will provide insight into the latest controversial developments affecting ICUs. Industry Insights Sessions take place in a relaxed setting off site, and attendance is free.

Saturday, February 15, 2020

5:30 p.m. - 7:30 p.m.

Tapas and Technology With a Live Demo of SeptiCyte™ RAPID Test
Organized by: Immunexpress
Presenters: Steven P. LaRosa, Russell R. Miller III
Location: Florida Ballroom A, Hyatt Regency Orlando
Register online

A cocktail reception showcasing the new SeptiCyte™ RAPID test running on the Idylla™ platform. Guests will have an opportunity to network with their peers and learn about SeptiCyte™ RAPID, a host response test, with actionable results in approximately one hour, differentiating sepsis from systemic inflammatory response syndrome (SIRS) with high negative predictive value (NPV), thus expediting and improving patient management for critically ill patients being admitted to the ICU. Steven P. LaRosa, MD, will address the challenges of current sepsis diagnosis and a new alternative approach leveraging the host immune response while Russell Miller, MD, will present highlights from the VENUS study, a clinical validation of SeptiCyte™ LAB.

Sunday, February 16, 2020

6:00 p.m. - 7:30 p.m.

Vascular Access in the Era of Central Line Avoidance
Organized by: BD Medical
Presenters: Gregory J. Schears, Judith Jacobi, Cheryl Gordon, Mark Stranz, Mark Rupp
Location: Plaza Ballroom Salon I, Hyatt Regency Orlando
Register online

How do you manage your critical patient without a central line? The era of central line avoidance creates challenges for clinicians when balancing risks and improving patient outcomes. A multidisciplinary panel will tackle topics of device insertion, medication infusion, and infection reporting.

6:00 p.m. - 7:30 p.m.
A Breakthrough in aTTP Treatment
Organized by: Sanofi Genzyme
Presenters: Muhammad Raza
Location: Plaza Ballroom Salon F, Hyatt Regency Orlando
Register online

The program will demonstrate the importance of rapid diagnosis and treatment of aTTP, particularly in the critical care setting, with a focus on current treatment options for adult patients with aTTP.

Monday, February 17, 2020

6:00 p.m. - 7:30 p.m.
Evidence-Based Approach to Anticoagulation Therapy for DVT/PE
Organized by: Janssen Pharmaceuticals, Inc.
Presenters: Victor F. Tapson
Location: Plaza Ballroom Salon I, Hyatt Regency Orlando
Registration: Attendees are able to attend on a first-come, first-served basis.

This lecture will discuss treatment options for patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and how they may reduce the risk of recurrent thrombotic events.
 
Visit the Exhibit Hall to gain new ideas and a heightened level of awareness on clinical topics and new technologies through in-booth learning opportunities. In-booth education will take place during regular Exhibit Hall hours.

Exhibit Dates
Sunday, February 16, 2020     9:30 a.m. - 3:45 p.m.            
Monday, February 17, 2020     8:30 a.m. - 3:30 p.m.          
Tuesday, February 18, 2020    8:30 a.m. - 1:30 p.m.   


Booth #811
3D Systems Simbionix
Stop by anytime for a hands-on opportunity to experience the U/S Mentor, an ultrasound simulator that features bedside echocardiography and much more, and demo the BRONCH Express portable virtual reality simulator for Endobronchial Ultrasound – Transbronchial Needle Aspiration (EBUS-TBNA) training.

Booth #723
Ceribell, Inc.

Please visit the Ceribell Booth (#723) to learn about our Rapid Response EEG system. With Clarity, Ceribell offers 24/7 continuous bedside EEG monitoring and alert. We will perform live demos where you can record, view, and listen to your own brainwaves.

Booth #920
CoapTech

CoapTech visitors will learn about consult-free, bedside gastrostomy tube placement using ultrasound guidance—perfect for intensivists, POCUS specialists, or anyone looking to expand her/his repertoire. Explore PUMA-G System: a novel gastrostomy tube placement system for critical care providers, leveraging your existing skills with ultrasound, balloons, and guidewires.

Booth #600
ECMO Advantage

Visit ECMO Advantage at booth #600 to learn more about:
  • ECMO cannulation and initiation
  • Developing an ECMO program
  • Recognizing and managing recirculation
  • High-fidelity simulation and training
  • How to develop highly skilled ECMO specialists in a low-volume program
  • www.ECMOAdvantage.com

Booth #709
Edwards Lifescience

Acumen Hypotension Prediction Index (HPI) Software Demo. Reserve your demo to learn how you can stay ahead of hypotension with this first-of-its-kind predictive software. Join us for in-booth simulation sessions to experience the latest simulation software as we dive into addressing critical clinical scenarios:
Sunday, February 16, 2020 • 9:45 a.m. – 10:15 a.m.
Sunday, February 16, 2020 • 3:00 p.m. – 3:30 p.m.
Monday, February 17, 2020 • 9:00 a.m. – 9:30 a.m.

Booth #410
Etiometry, Inc.

Experience the technology that just earned the world’s first FDA clearance for two critical care algorithms. A touchscreen, desktop, and iPad will be waiting for you with real-life use cases to explore and configure. Only at booth #410.

Booth #801
GE Healthcare

Come to GE Healthcare’s booth #801 for live ultrasound scanning demonstrations. Learn how you can simplify assessments and deliver effective care with Venue Go. And see how our AI-enabled auto tools can help clinicians make fast assessments and confident decisions.

Booth #817
Mindray

Mindray invites you to touch the future with our intuitive BeneVision N-Series patient monitors and TE7 ultrasound system for point of care. Learn more about the advanced cardiac assessment tools on the TE7 and M9 ultrasound machines, including tissue tracking and TEE, and join us for hands-on experience scanning a live model.

Booth #1133
Philips Healthcare

One-on-one solution demos and education on how Philips is connecting care from bedside to webside, from point of care to remote, patient-focused clinical surveillance, to enhance patient outcomes, standardize care and quality, and transform acute care delivery.

Booth #301
Teleflex

The NEW Arrow® CVC max barrier kit innovation – ErgoPack® Complete Learning Objectives:
  • Review the new ErgoPack® Complete and innovation of Arrow® GlideWheel™ Advancer
  • Reinforce the alignment of Arrow® with guidelines
  • Share the standardization of probe covers in acknowledgement of guidelines recommending ultrasound use  
  • Review insertion technique with new insertion components
  • Designated times:
    • Sunday, February 16, 2020 10:00 a.m. – 10:15 a.m. 11:00 a.m. – 11:15 a.m. 2:00 p.m. – 2:15 p.m.
    • Monday, February 17, 2020 10:00 a.m. – 10:15 a.m. 11:00 a.m. – 11:15 a.m. 2:00 p.m. – 2:15 p.m.
Attend exhibitor-sponsored industry education workshops during session breaks. Located in the Exhibit Hall, these workshops will provide additional learning opportunities and insight on late-breaking technology or clinical techniques. Presentations will be held in theaters 1 and 2 in Exhibit Hall C.

Sunday, February 16, 2020
9:40 A.M. -10:40 A.M.

Theater 2 
Targeting Interferon Gamma In Primary Hemophagocytic Lymphohistiocytosis
Sponsored by Sobi, Inc.
Presenter: Owen Wilson

Primary hemophagocytic lymphohistiocytosis (HLH) is a frequently misdiagnosed rare genetic disorder that requires immediate therapy to control hyperinflammation. This rapidly progressive disease can be fatal if left untreated. Without timely diagnosis and effective treatment, the median survival for patients with primary HLH is under 2 months. There has been a clear need for a more targeted option with an established safety profile to treat patients with primary HLH. This session will focus on two areas: 1) signs and symptoms of primary HLH to help accelerate diagnosis and 2) subduing the cytokine storm in primary HLH by targeting interferon gamma (IFNγ) to restrain hyperinflammation.

12:55 P.M.-1:55 P.M.
Theater 1

Reversal of Specific Direct Oral Anticoagulants In Patients Experiencing Life-Threatening Bleeds
Sponsored by Portola Pharmaceuticals, Inc.
Presenter: James Williams
Please RSVP here: www.hlxregister.com Code: 4ZWSGC

Reversal of specific direct oral anticoagulants in patients experiencing life-threatening bleeds: review of clinical evidence and practical recommendations for patient management.

Theater 2
Cardiogenic Shock: Identify, Initiate, Evaluate, Escalate
Sponsored by Getinge
Presenters: David Baran, Erik Osborn

Patients with cardiogenic shock represent a wide spectrum of disease that requires tailored therapy to improve hemodynamic derangements. Any attempt to improve outcomes in cardiogenic shock should begin with its early identification. The panel will discuss the new Society for ardiovascular Angiography and Interventions classification, initiation of treatment, evaluation, and adjustment in treatment plan.

2:45 P.M. – 3:45 P.M.
Theater 1

Use of Biomarkers to Manage ICU Patients With Respiratory Infections and Sepsis
Sponsored by Thermo Fisher Scientific
Presenter: Michael S. Niederman

Michael S. Niederman, MD, will discuss the role of biomarkers in managing and improving disposition of ICU patients with respiratory infections and sepsis.
  • Describe the role of biomarkers in the diagnosis of sepsis and respiratory infections and their ability to predict clinical outcome
  • Define the biology and kinetics of procalcitonin and other biomarkers used in the management of sepsis and respiratory infections
  • Discuss the rationale and evidence for procalcitonin use in antibiotic stewardship in the ICU

Monday, February 17, 2020
8:55 A.M. – 9:55 A.M.

Theater 1
Urgent Warfarin Reversal: A Case-Based Presentation

Sponsored by CSL Behring
Presenter: Aryeh Shander

This presentation will explore case scenarios in which reversal of warfarin is required in patients experiencing acute major bleeding, as well as in those in need of urgent surgery/invasive procedures.

Theater 2
Hypervolemia in the ICU: A Novel Approach to Fluid Management

Sponsored by CHF Solutions, Inc.
Presenter: Mehdi Oloomi

Hypervolemia is a common complication in the ICU and is associated with increased length of stay and mortality. Ultrafiltration with Aquadex FlexFlow® allows for timely treatment and can be prescribed by any physician trained in extracorporeal therapy. Ultrafiltration has been shown to reduce certain post-operative complications and improve cardiac performance.

12:25 P.M. – 1:25 P.M.

Theater 1
Under-Recognized Prevalence of Nonconvulsive Status Epilepticus and a Novel Rapid Response EEG

Sponsored by Ceribell
Presenters: Jake Adams, Paul M. Vespa
  • Discuss the prevalence of nonconvulsive status epilepticus and current diagnostic challenges
  • Explore how critically ill patients can benefit from rapid EEG with automatic bedside monitoring and alerts
  • Learn about the latest clinical data and real-world experiences using the Ceribell Rapid Response EEG with Clarity Complimentary lunch will be provided.
Theater 2
No Mask. No Problem®. Mask-Free NIV™ for Spontaneously Breathing Patients

Sponsored by Vapotherm, Inc.
Presenter: Jaime Betancourt
Registration: https://offers.vapotherm.com/sccm-2020-vapotherm-workshop
Attendees will learn about the physiologic basis of high-velocity nasal insufflation (HVNI) as a form of noninvasive ventilation (NIV), learn the mechanisms of action for how HVNI impacts physiology, and hear clinical data supporting HVNI as noninferior to bilevel positive airway pressure in the management of undifferentiated respiratory distress. Jaime Betancourt, MD, has over 18 years’ experience as a physician, including more than three years’ experience practicing in an emergency medicine setting, two-and-a-half years as a hospitalist, and eight years’ experience as a pulmonary intensivist in the greater Los Angeles area. Dr. Betancourt is board-certified in internal medicine, pulmonary diseases, and critical care medicine. He performs extensive clinical teaching activities with medical students, internal medicine residents, and pulmonary and critical care fellows.

Tuesday, February 18, 2020

8:55 A.M. - 9:55 A.M.
Theater 1
Optimizing Antimicrobial Stewardship by Combining Multiplex PCR and Biomarker Results

Sponsored by bioMérieux Inc.
Presenter: Devendra N. Amin

This workshop will explore how combining VIDAS® B•R•A•H•M•S PCT TM (procalcitonin) and BIOFIRE® FILMARRAY® Respiratory Panel results can optimize antimicrobial stewardship in patients with lower respiratory tract infections.

12:25 P.M. – 1:25 P.M. 
Theater 1
Molecular Diagnostics for Pneumonia: A Clinical Evaluation of the BioFire® FilmArray® Pneumonia Panel
Sponsored by BioFire Diagnostics, LLC
Presenter: Richard G. Wunderink

Molecular diagnostics for lower respiratory tract infections offer increased sensitivity and reduced turnaround time compared to bacterial culture. In this workshop, Richard G. Wunderink, MD, will discuss molecular diagnostics for pneumonia and present results and a patient case from an initial clinical evaluation of the BioFire Pneumonia Panel.